P3 Health Partners Inc.
PIII
$8.89
$0.222.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.48% | 25.38% | 23.31% | 25.49% | 20.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.48% | 25.38% | 23.31% | 25.49% | 20.67% |
| Cost of Revenue | 26.29% | 33.50% | 25.39% | 23.61% | 16.79% |
| Gross Profit | -286.24% | -196.89% | -66.22% | 1,991.08% | 508.04% |
| SG&A Expenses | -4.35% | -20.03% | -22.78% | -29.02% | -22.65% |
| Depreciation & Amortization | -0.71% | -0.58% | -0.63% | -0.46% | -0.70% |
| Other Operating Expenses | 522.65% | 216.08% | -230.31% | -237.10% | -10.84% |
| Total Operating Expenses | 26.84% | 27.67% | 17.57% | 14.77% | 10.72% |
| Operating Income | -89.84% | -42.95% | 14.62% | 32.84% | 31.72% |
| Income Before Tax | -66.54% | 61.49% | 73.41% | 88.45% | 88.22% |
| Income Tax Expenses | 62.78% | -56.92% | 119.47% | 108.04% | 44.74% |
| Earnings from Continuing Operations | -66.49% | 61.47% | 72.73% | 88.18% | 88.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 35.66% | -71.79% | -79.17% | -90.94% | -90.04% |
| Net Income | -135.14% | 18.71% | 44.07% | 74.97% | 78.61% |
| EBIT | -89.84% | -42.95% | 14.62% | 32.84% | 31.72% |
| EBITDA | -186.43% | -85.19% | 25.15% | 50.96% | 48.79% |
| EPS Basic | -59.34% | 71.99% | 79.50% | 90.93% | 90.00% |
| Normalized Basic EPS | -159.91% | -100.69% | -99.73% | -99.86% | -98.96% |
| EPS Diluted | -16.58% | 54.65% | 63.89% | 85.03% | 84.17% |
| Normalized Diluted EPS | -160.44% | -100.68% | -99.77% | -99.74% | -97.83% |
| Average Basic Shares Outstanding | 41.06% | 74.75% | 108.86% | 174.05% | 127.57% |
| Average Diluted Shares Outstanding | -6.20% | 7.28% | 58.64% | 15.14% | 1.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |